Drug

Polastro dubbed the combined markets of China and India as

Dispatches from DCAT Week

'Chindia' drug substance market not to be discounted

By Melissa Fassbender

China and India are causing a “tsunami” in the drug substance market – yet significant hurdles may bring fine chemical outsourcing back to the West.

Online customers are prey to fake pharmacies, says MHRA

MHRA uncovers $1m illegal ED drug haul

By Fiona BARRY

A UK man has been sentenced to 16 months in prison for smuggling illegal erectile dysfunction drugs following an MHRA investigation.

Charles River seeing more strategic relationships, CEO says

Charles River seeing more strategic relationships, CEO says

By Zachary Brennan

As Big Pharma and biotech companies continue to outsource more of their work, one of the leaders in the preclinical and discovery space – Charles River Laboratories – is seeing more strategic relationships with both large and small clients, CEO James...

Rx-360 pushes into China with new working group

Rx-360 pushes into China with new working group

By Zachary Brennan

Supply chain security consortium Rx-360 has shifted its focus to China where it is forming a working group to further ensure compliance in a country that has had some difficulties with spurious drugs in the past.

Operation Pangea takes another crack at illegal drugs, websites

Operation Pangea takes another crack at illegal drugs, websites

By Zachary Brennan

For the seventh time since 2006, law enforcement, customs, and regulatory authorities from 111 countries collaborated to identify and root out Internet-based makers and distributors of illegal drug products and medical devices.

Recipharm given the go-ahead in France

Recipharm gets OK in France

Swedish CDMO Recipharm has been cleared by French regulators to fill biotech drug products at its site in Tours.

Late phase clinical trials: Where the business is at, says PRA

PRA focuses on late phase services

By Natalie Morrison

PRA has expanded its operations in the Netherlands and the UK in a bid to meet what it says is soaring client demand for late phase and product registration services.

Regulatory expert insight: electronic submission

Regulatory expert insight: electronic submission

By Gareth Macdonald and Claire Videau

Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers